Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

Share Price is delayed by 15 minutes
Get Live Data
26.60    0.00 (0.00%)
Bid:
22.60
Ask:
23.60
Spread: 1.00 (4.425%)
Market Cap: $51.18b
CPIC Live PriceLast checked at - London Stock Exchange

Intraday China Pacific Share Chart

  • This share is an international stock.

2021 Interim Report

1 Sep 2021 07:00

RNS Number : 0880K
China Pacific Insurance Grp Co. Ltd
29 August 2021
 

 

29 August 2021

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

2021 Interim Report

China Pacific Insurance (Group) Co., Ltd. (the "Company" or "CPIC") hereby announces the 2021 Interim Report. For details, please visit: http://www.rns-pdf.londonstockexchange.com/rns/0880K_1-2021-8-29.pdf

 

The 2021 Interim Report was also published on the Company's website at http://www.cpic.com.cn/gdr/gdrggen/ on 29 August 2021.

 

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

KONG Qingwei

Chairman

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) 596/2014.

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCPLMLTMTTTMAB
Date   Source Headline
28th Apr 202510:43 amRNSApproval of Director's Appointment Qualification
25th Apr 202510:53 amRNSSummaries of the Quarterly Solvency Reports
25th Apr 202510:51 amRNS2025 First Quarter Report
22nd Apr 202512:00 pmRNS2024 Sustainability Report
11th Apr 202511:36 amRNSAnnouncement relating to Premium Income
7th Apr 202510:21 amRNSResignation of Director of the Board
26th Mar 202512:00 pmRNSPublication of Summaries of Solvency Reports
26th Mar 202511:31 amRNSPublication of Annual Results Presentation
26th Mar 202511:14 amRNSCPIC 2024 Annual Report
21st Mar 202510:46 amRNSChange of Chairman of a Subsidiary
21st Mar 202510:43 amRNSResignation of Chairman of a Subsidiary
18th Mar 20259:44 amRNSConvening of 2024 Annual Results Presentation
14th Mar 202510:07 amRNSAnnouncement relating to Premium Income
18th Feb 20259:36 amRNSAnnouncement relating to Premium Income
24th Jan 202510:04 amRNSAnn on Approval of Appointment Qualifications
22nd Jan 202510:36 amRNSAnn on Estimated Increase in 2024 Annual Earnings
16th Jan 20259:22 amRNSAnnouncement relating to Premium Income
27th Dec 202410:50 amRNSApproval of Appointment Qualification
13th Dec 20248:46 amRNSPDMR Shareholding
11th Dec 20249:17 amRNSAnnouncement relating to Premium Income
14th Nov 20248:53 amRNSAnnouncement relating to Premium Income
30th Oct 20249:28 amRNSPublication of Summaries of Solvency Reports
30th Oct 20249:23 amRNSAdjustment to the Composition of Special Committee
30th Oct 20249:19 amRNSAppointment of Chairman and Vice Chairwoman of BOS
30th Oct 20249:19 amRNSAppointment of VP and Change of CFO
30th Oct 20249:04 amRNS2024 Third Quarter Report
21st Oct 202410:17 amRNS2024 Q3 Results Presentation
16th Oct 202410:40 amRNSAnnouncement relating to Premium Income
15th Oct 202410:32 amRNSEstimated Increase for the First Three Quarters
14th Oct 202411:58 amRNSAnnouncement on Poll Results for the EGM
30th Sep 20249:37 amRNSAnnouncement on approval of AoA by NFRA
30th Sep 20249:36 amRNSApproval of Directors’ Appointment Qualifications
20th Sep 202410:37 amRNSNotice of the EGM
20th Sep 202410:31 amRNSApproval of Supervisors' Appointment Qualification
13th Sep 202410:06 amRNSPDMR Shareholding
11th Sep 20249:45 amRNSAnnouncement relating to Premium Income
10th Sep 20247:48 amRNSPDMR Shareholding
29th Aug 20241:17 pmRNSPublication of Summaries of Solvency Reports
29th Aug 20241:11 pmRNSPublication of 2024 Interim Results Presentation
29th Aug 20241:03 pmRNSCPIC 2024 Interim Report
29th Aug 202412:08 pmRNSResignation of Director of the Board
28th Aug 202410:33 amRNSResignation of Chairwoman of a Subsidiary
21st Aug 202410:12 amRNSConvening of 2024 Interim Results Presentation
13th Aug 202410:26 amRNSAnnouncement relating to Premium Income
25th Jul 20247:00 amRNSDirector Shareholding
16th Jul 202410:38 amRNSAnnouncement relating to Premium Income
11th Jun 202410:23 amRNSAnnouncement relating to Premium Income
6th Jun 202411:31 amRNSResult of 2023 AGM
3rd Jun 202410:29 amRNSPDMR Shareholding
28th May 202410:47 amRNSElection of Employee Representative Supervisors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.